BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Massachusetts General Hospital
Boston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Massachusetts General Hospital (6)
2023
-
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
Blood Advances
-
Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients
Seminars in Hematology
-
Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials
Seminars in Hematology
2021
-
Denosumab compared with zoledronic acid on PFS in multiple myeloma: Exploratory results of an international phase 3 study
Blood Advances, Vol. 5, Núm. 3, pp. 725-736
2019
-
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
The Lancet Oncology, Vol. 20, Núm. 6, pp. e302-e312
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557